ConductScience.org, home

Paper39301237

Unveiling multifunctional inhibitors: holistic spectral, electronic and molecular characterization, coupled with biological profiling of substituted pyridine derivatives against LD transpeptidase, heme oxygenase and PPAR gamma.

Begum SY and 7 others. RSC Adv, 2024. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Unveiling multifunctional inhibitors: holistic spectral, electronic and molecular characterization, coupled with biological profiling of substituted pyridine derivatives against LD transpeptidase, heme oxygenase and PPAR gamma. Papers, record 39301237. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39301237

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Unveiling multifunctional inhibitors: holistic spectral, electronic and molecular characterization, coupled with biological profiling of substituted pyridine derivatives against LD transpeptidase, heme oxygenase and PPAR gamma.
PubMed
Journal
RSC Adv
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.92, provisional
iCite
Revised in PubMed
2024-09-21
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Begum SYShaik Yasmin
2Imran PMPredhanekar Mohamedhttps://orcid.org/0000-0002-5556-4116
3Kubaib AAttarhttps://orcid.org/0000-0003-0909-0391
4Yassin MTMohamed Taha
5Al-Otibi FOFatimah O
6Selvakumaran MM
7Basha AAA Aathifhttps://orcid.org/0000-0002-0415-327X
8Sulthanudeen SS

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138562526Physicochemical properties, pharmacokinetic studies, DFT approach, and antioxidant activity of nitro and chloro indolinone derivatives.Front Chem2024https://conductscience.org/library/papers/38562526PubMed
238675469Unveiling the Potential of Ent-Kaurane Diterpenoids: Multifaceted Natural Products for Drug Discovery.Pharmaceuticals (Basel)2024https://conductscience.org/library/papers/38675469PubMed
3385223912,3-Dichloronaphthoquinone derivatives: Synthesis, antimicrobial activity, molecular modelling and ADMET studies.Bioorg Chem2024https://conductscience.org/library/papers/38522391PubMed
433550683Inhibition of α-glucosidase and α-amylase by herbal compounds for the treatment of type 2 diabetes: A validation of in silico reverse docking with in vitro enzyme assays.J Diabetes2021https://conductscience.org/library/papers/33550683PubMed
538500408A Comprehensive Examination of Heterocyclic Scaffold Chemistry for Antitubercular Activity.Chem Biodivers2024https://conductscience.org/library/papers/38500408PubMed
621128600Design, synthesis, and structural analysis of phenylpropanoic acid-type PPARγ-selective agonists: discovery of reversed stereochemistry-activity relationship.J Med Chem2011https://conductscience.org/library/papers/21128600PubMed
722162017Multiwfn: a multifunctional wavefunction analyzer.J Comput Chem2012https://conductscience.org/library/papers/22162017PubMed
833063271Ciprofloxacin and moxifloxacin could interact with SARS-CoV-2 protease: preliminary in silico analysis.Pharmacol Rep2020https://conductscience.org/library/papers/33063271PubMed
936558921Cyclooxygenase-2 (COX-2) as a Target of Anticancer Agents: A Review of Novel Synthesized Scaffolds Having Anticancer and COX-2 Inhibitory Potentialities.Pharmaceuticals (Basel)2022https://conductscience.org/library/papers/36558921PubMed
1038318567Facile Microwave-Assisted Hydrothermal Synthesis of Copper Oxide Nanoneedle Arrays for Practical Biomedical Applications.Cureus2024https://conductscience.org/library/papers/38318567PubMed
1139062004
Phytochemical Characterization and Antioxidant Activity Evaluation for Some Plant Extracts in Conjunction with Pharmacological Mechanism Prediction: Insights into Potential Therapeutic Applications in Dyslipidemia and Obesity.
Biomedicines2024https://conductscience.org/library/papers/39062004PubMed
1238792094N-Heterocycles as Promising Antiviral Agents: A Comprehensive Overview.Molecules2024https://conductscience.org/library/papers/38792094PubMed
1337628906Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents.Int J Mol Sci2023https://conductscience.org/library/papers/37628906PubMed
1435628466Pyridine Compounds with Antimicrobial and Antiviral Activities.Int J Mol Sci2022https://conductscience.org/library/papers/35628466PubMed
1517534530Structure and catalytic mechanism of heme oxygenase.Nat Prod Rep2007https://conductscience.org/library/papers/17534530PubMed
1631956713New thiazole, pyridine and pyrazole derivatives as antioxidant candidates: synthesis, DFT calculations and molecular docking study.Heliyon2020https://conductscience.org/library/papers/31956713PubMed
1738450660In silico design, synthesis and antitubercular activity of novel 2-acylhydrazono-5-arylmethylene-4-thiazolidinones as enoyl-acyl carrier protein reductase inhibitors.J Biomol Struct Dyn2025https://conductscience.org/library/papers/38450660PubMed
1837005457Pyrazole derivatives of pyridine and naphthyridine as proapoptotic agents in cervical and breast cancer cells.Sci Rep2023https://conductscience.org/library/papers/37005457PubMed
1927820797Non-classical transpeptidases yield insight into new antibacterials.Nat Chem Biol2017https://conductscience.org/library/papers/27820797PubMed

Download CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn Papers
41407765Comprehensive Theoretical, Spectroscopic, Solvent, Topological and Antimicrobial investigation of 5-Chloro-6-fluoro-2-(2-pyrazinyl)-1H-benzimidazole.Sci Rep2025https://conductscience.org/library/papers/41407765

Source PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
PPARG5468PubTator's text mininghttps://conductscience.org/library/genes/5468

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39301237

GET https://conductscience.org/api/papers/v1/39301237/authors